An article in Chinese medical technology media platform VCBeat revealed that Bayer’s G4A startup round in China has produced a partnership with VeChain to collect and track supply chain data for Bayer’s clinical trials. The platform, known as Csecure, can monitor user and product data entered into the platform to ensure it is consistent throughout the trial, leading to improved safety and precision.
[translated from Chinese] After this partnership with Bayer, our greatest feeling was their rigor [precisness] towards the medical industry. This precision extends beyond just product design to include precision in communication, and in with communication between Bayer’s related business departments. We can really feel the complete meticulous attitude that Bayer has for the medical and health cause. – Sunny Lu, VeChain CEO
The article featured an interview with G4A Project Manager Ding Songen, who spoke about the importance of startups in Bayer’s own corporate structure. He pointed out that technical strengths alone were insufficient, and that Bayer looked at other factors like quality of the company’s team, project experience, value proposition, and even the financial situation of company. This led to a cooperation with VeChain as Bayer looks to improve the management of clinical trial drugs.
Ding continued to state that Bayer has been exploring the G4A program in China since 2016. “In the continuous communication with Chinese local start-ups, our understanding of the field of digital health is also deepening. In the end, G4A tried to find a new entry point in the field of digital health to achieve the goal of shaping a new health experience.”
The G4A partnership could have a lot of advantages for VeChain. In addition to CSecure being used internally with Bayer, G4A partners gain access to exclusive mentors, networking opportunities, and regional support. The whole process of engaging with such a large medical organization should bring valuable experience for VeChain’s product development team, as they better understand the professional needs of a leading medical enterprise.
We engage with the brightest minds both inside and outside of Bayer while identifying emerging trends and needs at the intersection of humans and technology, and transform them into new products and solutions for people. -GFA Website Mission Statement
Source: VCBeat
Latest Posts
Humans of Blockchain: Jason Rockwood
Recap: PwC and VeChain speak at British Chamber of Commerce Event in Shanghai
